
Stock Trend Analysis Report
Prepared for you on Monday, October 2, 2023.
Altamira Therapeutics Ltd. - Common Shares (NASDAQ:CYTO)
Crossroads (-60) - CYTO is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CYTO?
MarketClub looks at technical strength and momentum to determine if the timing is right for CYTO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
![]() |
|||||||||||||||
|
MarketClub’s Trade Triangles for CYTO
The long-term trend has been DOWN since Jun 10th, 2022 at 0.6208
The intermediate-term trend has been UP since Sep 14th, 2023 at 0.3810
The short-term trend has been UP since Sep 26th, 2023 at 0.2547
Smart Scan Analysis for CYTO
Based on our trend formula, CYTO is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Open | High | Low | Price | Change |
---|---|---|---|---|
0.2445 | 0.2446 | 0.2200 | 0.2225 | -0.0220 |
Prev. Close | Volume | Bid | Ask | Time |
0.2445 | 154698 | 2023-10-02 15:36:38 |
52wk High | 13.52 | 52wk High Date | 2022-10-21 |
52wk Low | 0.22 | 52wk Low Date | 2023-09-26 |
Average Volume | 592,968 | Shares Outstanding | 571 |
Assets | 18,838,598M | Liabilities | 6,134,070M |
P/E Ratio | -1.90960000 |